| Brittany Marino, | |
|
1140 N Main Street Ext, Butler, PA 16001-1957 | |
| (636) 887-1011 | |
| Not Available |
| Full Name | Brittany Marino |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1140 N Main Street Ext, Butler, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295317345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WM0705X | Registered Nurse - Medical-surgical | 2017024664 (Missouri) | Secondary |
| 207Q00000X | Family Medicine | RN723890 (Pennsylvania) | Primary |
| Entity Name | Geskin Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447812607 PECOS PAC ID: 4981006640 Enrollment ID: O20210719000151 |
News Archive
A George Washington University professor has designed new technology that can identify traces of chemicals at 10-19 moles, a previously undetectable amount. This minute quantity can be conceptualized as 10 times below a billionth of a billionth of a teaspoon of water.
Urgent Matters, Blue Jay Consulting, and Schumacher Group are pleased to announce the winners of the Emergency Care Innovation of the Year Award, a newly created competition to foster innovation in emergency departments nationwide.
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Marino, 1060 Stonebrooke Ln, Wentzville, MO 63385-3158 Ph: (636) 887-1011 | Brittany Marino, 1140 N Main Street Ext, Butler, PA 16001-1957 Ph: (636) 887-1011 |
News Archive
A George Washington University professor has designed new technology that can identify traces of chemicals at 10-19 moles, a previously undetectable amount. This minute quantity can be conceptualized as 10 times below a billionth of a billionth of a teaspoon of water.
Urgent Matters, Blue Jay Consulting, and Schumacher Group are pleased to announce the winners of the Emergency Care Innovation of the Year Award, a newly created competition to foster innovation in emergency departments nationwide.
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
› Verified 8 days ago